| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,047 |
18,509 |
$1.64M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,164 |
4,155 |
$333K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,909 |
4,623 |
$206K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,840 |
1,679 |
$178K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,749 |
3,542 |
$114K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,686 |
1,456 |
$79K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
701 |
694 |
$75K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
493 |
483 |
$50K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,402 |
2,775 |
$31K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
482 |
466 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
4,508 |
4,307 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,088 |
1,007 |
$15K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,475 |
1,364 |
$15K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
108 |
108 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
501 |
489 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
131 |
130 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
330 |
317 |
$5K |
| 99442 |
|
175 |
160 |
$4K |
| 99001 |
|
4,260 |
3,989 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
31 |
31 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
100 |
99 |
$3K |
| 83013 |
|
96 |
96 |
$3K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
12 |
12 |
$3K |
| 99401 |
|
171 |
165 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
131 |
131 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,415 |
1,075 |
$2K |
| 99000 |
|
568 |
549 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
973 |
878 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
216 |
215 |
$2K |
| 99441 |
|
78 |
73 |
$1K |
| 96127 |
|
426 |
423 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
12 |
12 |
$1K |
| 90658 |
|
82 |
82 |
$1K |
| 81025 |
|
124 |
121 |
$921.04 |
| 99407 |
|
59 |
53 |
$750.22 |
| 81005 |
|
631 |
608 |
$716.54 |
| 96160 |
|
443 |
427 |
$633.87 |
| 81003 |
|
308 |
297 |
$567.50 |
| 93000 |
|
53 |
52 |
$474.77 |
| 87420 |
|
72 |
70 |
$423.95 |
| 86803 |
|
200 |
197 |
$385.20 |
| 81002 |
|
87 |
83 |
$253.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
315 |
299 |
$188.13 |
| 87299 |
|
12 |
12 |
$133.30 |
| 82947 |
|
35 |
26 |
$114.20 |
| 90715 |
|
59 |
59 |
$41.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
16 |
$24.49 |
| 82784 |
|
14 |
14 |
$15.40 |
| 86703 |
|
52 |
49 |
$11.86 |
| 3011F |
|
1,538 |
1,513 |
$2.89 |
| 3074F |
|
1,886 |
1,571 |
$2.37 |
| 3078F |
|
1,736 |
1,440 |
$1.94 |
| 1159F |
|
472 |
315 |
$1.53 |
| 98960 |
|
635 |
625 |
$1.42 |
| 3008F |
|
849 |
832 |
$1.22 |
| 3079F |
|
710 |
600 |
$1.05 |
| 3075F |
|
348 |
308 |
$0.47 |
| 3077F |
|
300 |
255 |
$0.27 |
| 1160F |
|
35 |
29 |
$0.16 |
| 3080F |
|
93 |
85 |
$0.15 |
| 1033F |
|
65 |
64 |
$0.14 |
| 4019F |
|
53 |
50 |
$0.11 |
| 90749 |
|
45 |
44 |
$0.09 |
| 3044F |
|
1,379 |
1,358 |
$0.02 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
129 |
127 |
$0.00 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
1,889 |
1,843 |
$0.00 |
| 97802 |
|
149 |
149 |
$0.00 |
| 2000F |
|
139 |
138 |
$0.00 |
| M1296 |
Bmi is documented within normal parameters and no follow-up plan is required |
25 |
25 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
599 |
430 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
186 |
158 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
100 |
98 |
$0.00 |
| G9273 |
Blood pressure has a systolic value of < 140 and a diastolic value of < 90 |
61 |
60 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
79 |
73 |
$0.00 |
| 90734 |
|
66 |
66 |
$0.00 |
| 3725F |
|
104 |
103 |
$0.00 |
| 99072 |
|
2,390 |
2,255 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
78 |
76 |
$0.00 |
| 90461 |
|
119 |
115 |
$0.00 |
| 4004F |
|
51 |
44 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
30 |
27 |
$0.00 |